Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy

Maria Jordan, Angelika Stucki-Koch, Maximilian Schinke, Lena Willmer, Ingrid Senne, Naisam Abbas, Marco Bentele, Dana Oldenkott, Nico Lachmann, Linda Feldbrügge, Resa Puffert, Josef Fangmann, Robert Ramm, Thomas Thum, Katherina Sewald, Kevin Schmidt, Jan Fiedler

Open source

DOI: 10.1007/s00109-026-02695-5
Published: 2026-06-25
Container: Journal of Molecular Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00109-026-02695-5,
  title = {Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy},
  author = {Maria Jordan and Angelika Stucki-Koch and Maximilian Schinke and Lena Willmer and Ingrid Senne and Naisam Abbas and Marco Bentele and Dana Oldenkott and Nico Lachmann and Linda Feldbrügge and Resa Puffert and Josef Fangmann and Robert Ramm and Thomas Thum and Katherina Sewald and Kevin Schmidt and Jan Fiedler},
  year = {2026},
  journal = {Journal of Molecular Medicine},
  doi = {10.1007/s00109-026-02695-5},
  url = {https://doi.org/10.1007/s00109-026-02695-5}
}

RIS

TY  - JOUR
TI  - Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy
AU  - Maria Jordan
AU  - Angelika Stucki-Koch
AU  - Maximilian Schinke
AU  - Lena Willmer
AU  - Ingrid Senne
AU  - Naisam Abbas
AU  - Marco Bentele
AU  - Dana Oldenkott
AU  - Nico Lachmann
AU  - Linda Feldbrügge
AU  - Resa Puffert
AU  - Josef Fangmann
AU  - Robert Ramm
AU  - Thomas Thum
AU  - Katherina Sewald
AU  - Kevin Schmidt
AU  - Jan Fiedler
PY  - 2026
JO  - Journal of Molecular Medicine
DO  - 10.1007/s00109-026-02695-5
UR  - https://doi.org/10.1007/s00109-026-02695-5
ER  -

APA

Jordan, M., Stucki-Koch, A., Schinke, M., Willmer, L., Senne, I., Abbas, N., Bentele, M., Oldenkott, D., Lachmann, N., Feldbrügge, L., Puffert, R., Fangmann, J., Ramm, R., Thum, T., Sewald, K., Schmidt, K., & Fiedler, J. (2026). Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-026-02695-5

Source records

crossref · retrieved 2026-09-27T02:02:52.947Z